EW:NYSE
Edwards Lifesciences Corp
USDÂ 93.58
arrow_upward
+1.94%(+1.78) 1H
29 Okt, 10:27:47 PG GMT-4 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk EW...
Buka
USDÂ 92.63
Tinggi
USDÂ 93.98
Rendah
USDÂ 89.90
Permodalan Pasaran
53.94B
Purata volum
3.52J
Volum
535.45K
Nisbah H/P
54.14
tgi 52 mgu
USDÂ 96.29
rdh 52 mgu
USDÂ 74.66
EPS
USDÂ 1.73
Beta
0.87
Syer tertunggak
576.40J
Bilangan pekerja
16K
Buka
USDÂ 92.63
Tinggi
USDÂ 93.98
Rendah
USDÂ 89.90
Permodalan Pasaran
53.94B
Purata volum
3.52J
Volum
535.45K
Nisbah H/P
54.14
tgi 52 mgu
USDÂ 96.29
rdh 52 mgu
USDÂ 74.66
EPS
USDÂ 1.73
Beta
0.87
Syer tertunggak
576.40J
Bilangan pekerja
16K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Seeking Alpha
·
2 jam lalu
Edwards Lifesciences Continually Innovating Ahead Of Q3 Results, Cardio Portfolio Thrives
Zacks
·
22 jam lalu
SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?
Investing.com
·
23 jam lalu
Edwards Lifesciences shares may move 7.6% on earnings report
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Perihal Edwards Lifesciences Corp
CEO-
Pekerja16K
Diasaskan1958
Ibu pejabatIrvine, California, Amerika Syarikat
Sektor-
Laman webedwards.com